Barriers to Tofersen Therapy for Variant SOD1-Mediated ALS

This Viewpoint advocates for the accelerated adoption of tofersen therapy to treat patients with variant SOD1 -mediated amyotrophic lateral sclerosis (ALS) and describes the current barriers to treatment.